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Endothelin-1 (ET-1) has been shown to have an important role
in diabetic nephropathy (DN). Here we investigated the contribution
of endothelial cell-derived ET-1 to the changes in renal phenotype
of diabetic mice. Therefore, we induced type 1 diabetes in vascular
endothelial cell-speciﬁc ET-1 knockout (VEETKO) mice and their wild
type (WT) littermates by streptozotocin injection (i.p. 50 mg/kg/day,
ﬁve consecutive days). After ten and 22 weeks of diabetes, we observed
an increase of food and water intake, urine volume and creatinine
clearance in both genotypes compared to non-diabetic mice. The renal
cortical expression of ET-1 mRNA was not signiﬁcantly activated by
diabetes. Nevertheless, VEETKO mice showed only about half of ET-1
mRNA expression compared to WT mice. Though, there were no sig-
niﬁcant differences in the renal function including albumin and protein
excretion between the genotypes. Based on hematocrit measurements,
neither diabetes nor ET-1 deﬁciency had an impact on ﬂuid retention.
After ten weeks of diabetes, systolic blood pressure measured by tail-
cuff method decreased in WT mice. After 22 weeks, heart rate and
systolic and diastolic blood pressurewere similar between all groups. At
baseline the kidneys of VEETKOmicewere signiﬁcantly heavier (+15%)
compared to WT mice but this gap was not observed in diabetic
condition. In contrast to previously presented data, in thismodel of type
1 diabetes we are not able to conﬁrm the pivotal role of endothelial cell
derived ET in the development of DN.
doi:10.1016/j.lfs.2013.12.082
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Background: Endothelin receptor antagonists reduce albuminuria
in diabetic patients. However, adverse effects related to ﬂuid retention
and attributed to the blocking of the tubular endothelin receptors
prevent the use of ERA clinically. The endothelin A (ETA) receptors
on podocytes might be implicated in albuminuria during diabetes.
We hypothesized that the suppression of the ETA receptors on the
podocytes may reduce albuminuria without affecting the tubular func-
tions. Methods and results: To address this question, we generated
podocyte speciﬁc ETA deﬁcient mice using ETA ﬂoxedmice matedwith
mice expressing the Cre recombinase under the control of the nephrin
gene (PodoETAKO mice). We induced type-1 diabetes in seven-week
old male PodoETAKO mice and their wild type (WT) littermates by
streptozotocin injection (i.p. 50 mg/kg/day, ﬁve consecutive days). A set
of animals were treated with macitentan, a dual ETA/ETB antagonist
(25 mg/kg/day, orally, mixed with food). The hyperglycemic mice
developed glomerular hyperﬁltration, renal hypertrophy, reduced serum
creatinine levels, albuminuria, tubular injury, glomerular hypertrophy
and inﬂammation. After 20 weeks of diabetes, the absence of ETA
receptors on podocytes had no effect on these parameters. Macitentan
treatment however reduced albuminuria and restored serum creatinine
levels in wild type mice. Interestingly, the effects of macitentan were
diminished in PodoETAKO mice. Similarly, macitentan increased
podocyte number per glomerulus (WT-1 positive cells) and glomerulus
size in WT but not in PodoETAKO mice. Neither ETA deﬁciency nor
macitentan treatment increased water retentionmeasured as free water
clearance. Conclusion: In contrast to systemic dual ETA/ETB receptor
blockade, the suppression of the ETA receptors on podocytes is not
antialbuminuric in diabetic mice.
doi:10.1016/j.lfs.2013.12.083
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Retinitis pigmentosa (RP) is an inherited retinal disorder char-
acterized by bone spicul pigment in the retina, attenuated retinal
blood vessels and a pale, waxy optic nerve head with early visual
ﬁeld contraction and decrease of the electroretinogram (ERG). Retinal
hemodynamic impairment is still present in early stages of RP and
various hypotheses have been advanced as to a cause. We studied
with multifocal electroretinogram (mfERG) of the macula and optical
coherence tomography (OCT) of the choroid 24 patients, 14 males and
10 females, aged 63–45 yrs. (mean 55 ± 7 yrs.) and affected by simplex
RP. The patients had a visual acuity of 0.1 log MAR with a mean defect
(MD) of the visual ﬁeld of −12.32 ± 8.48 dB, a pattern standard
deviation index (PSD) of 6.09 ± 4.22 dB and a b-wave electroretino-
gram (ERG) amplitude of 45.08 ± 8.24 &muV. An increase of endo-
thelin-1 (ET-1) plasma levels was found: 2.143 ± 0.258 pg/ml vs.
1.219 ± 0.236 pg/ml in non-RP controls (p b 0.002). The choroidal
thickness was 226.75 ± 76.37 μ vs. 303.9 ± 39.87 μ (p b 0.002) in
normal controls. The Spearman's correlation test highlighted that the
decrease of choroidal thickness (r =−0.702; p b 0.023) and the in-
crease of time latency in the rings 2 (r =−0.669; p b 0.034) and 3
(r = -0.883; p b 0.007) of mfERG were related to the increase of ET-1
plasma levels. It is thought that an increase in ET-1 in our RP could lead
to a vasoconstriction in the choroidal vessels and worsening the
abiotrophic process of the macular photoreceptors with increase of the
conduction implicit time.
doi:10.1016/j.lfs.2013.12.084
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Background: Percutaneous coronary intervention (PCI) is often
complicated by post-procedural myocardial necrosis as manifested
by elevated cardiac troponin. Plasma pentraxin 3 (PTX3) levels are
increased in patients with arterial inﬂammation, especially unstable
angina pectoris (AP). The study tested whether plasma PTX3 levels
can predict post-PCI cardiac troponin T (TnT) elevation. Methods:
We evaluated 94 consecutive patients with AP of normal pre-PCI TnT
levels who underwent PCI. Pre-PCI virtual histology-intravascular
ultrasound was performed to assess culprit plaque composition.
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Plasma PTX3 levels and serum hs-CRP levels were measured at pre-
PCI. Patients were divided into 2 groups according to the presence
(Group I, n = 34) or absence (Group II, n = 60) of post-PCI TnT
elevation N3 × the upper limit of normal at 24 h after PCI. Result:
Plasma PTX3 (4.06 ± 2.05 ng/ml vs 2.17 ± 1.02 ng/ml, P b 0.001)
and serum hs-CRP levels (0.25 ± 0.03 vs 0.16 ± 0.03, P = 0.048)
were signiﬁcantly higher in Group I than in Group II. Plaque burden
(80.9 ± 5.3 vs 75.4 ± 10.6%, P = 0.047), incidence of positive
remodeling (59 vs 25%, P = 0.034), and percent necrotic core area
(19.0 ± 7.4 vs 14.0 ± 5.9%, P = 0.046) were signiﬁcantly higher in
Group I than in Group II. By ROC analysis, plasma PTX3 levels (AUC
0.823) well discriminated prediction for post-PCI cardiac TnT ele-
vation in comparison with serum hs-CRP levels (AUC 0.618). Best
predictive values of plasma PTX3 levels were 2.83 ng/ml. In the
multiple logistic regression analysis, plasma PTX3 levels were most
independent predictors of post-PCI cardiac TnT elevation. Conclu-
sion: Plasma PTX3 levels may be a useful marker for predicting post-
PCI cardiac TnT elevation, which is associated with the inﬂammatory
status of culprit lesions.
doi:10.1016/j.lfs.2013.12.085
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Background: Suction ﬂow can be visualized with color Doppler
images. However, characteristics of suction ﬂow have never been
quantiﬁed. Vector ﬂow mapping (VFM) can be used to assess intra-
ventricular hemodynamics quantitatively. The purpose of the present
study was to assess the magnitude and timing of suction ﬂow kinetic
energy and to investigate the relationship between left ventricular
(LV) function and geometry in heart failure patients.
Methods: We studied 24 subjects with elevated LV ﬁlling pressure
(eFP group) and 36 normal subjects (normal group) were enrolled.
Suction was deﬁned as the apical ﬂow directing to the apex during the
period from soon after the ejection to before mitral inﬂow. Flow kinetic
energy was quantiﬁed as the sum of the products of blood mass and
velocity vector using VFM. We measured magnitude and time to peak
suction kinetic energy.
Results: Suction was recognized in 12 patients (50%) in the eFP
group and 36 subjects (100%) in the normal group. The eFP group
showed signiﬁcantly smaller suction kinetic energy than the normal
group (2.7 ± 3.8 vs. 5.7 ± 4.4 g/s/cm2, P b 0.01). The eFP group with
suction showed smaller LV end systolic volume (ESV) (P b 0.05), more
ellipsoidal geometry (P b 0.05), and greater untwisting rate (P b 0.01)
than those patients without suction. Regression analysis indicated
a signiﬁcant linear relation between suction kinetic energy and LVEF
(r = 0.48, P b 0.01), eccentricity index (r = 0.27, P = 0.04), and
untwisting rate (r = 0.03, P = 0.04).
Conclusion: Magnitude of the suction ﬂow kinetic energy derived
from VFM may allow quantitative assessment of suction ﬂow,
which correlates to LV systolic function, geometry, and untwisting
mechanics.
doi:10.1016/j.lfs.2013.12.086
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Introduction: Renal denervation (RDN) has been featured as a
novel treatment for hypertension. In animal models of hypertension,
a surgical RDN by cutting nerves with staining phenol has been
reported; however, a radiofrequency (RF) energy has been rarely
applied for RDN. We aimed to evaluate the effects of RF-RDN in
spontaneously hypertensive rats (SHR) and Wistar–Kyoto rats (WKY).
Methods: The RF energy was applied to the bilateral renal arteries by
using a 2 Fr catheter placed through an abdominal incision under
anesthesia in 8 SHR and 8 WKY. The sham operation was performed in
another 8 SHR and 8 WKY. The systolic and diastolic blood pressures
(BP) and urinary norepinephrine secretion were followed up for
3 months after the operations. The RDN was conﬁrmed by a decrease
in renal tissue norepinephrine content as compared to the sham
operation. Results: The RF-RDN in the SHR restrained a spontaneous
rise in systolic BP (46 ± 12% increase from158 ± 8 to 230 ± 14mmHg
vs. 21 ± 18% increase from 165 ± 9 to 197 ± 20mmHg, p = 0.012)
and diastolic BP (55 ± 27% increase from 117 ± 9 to 179 ± 23mmHg
vs. 28 ± 13% increase from 120 ± 7 to 154 ± 13 mmHg, p = 0.035).
The systolic and diastolic BP in the WKY, however, were not affected
by the RF-RDN. Although the RF-RDN did not affect the urinary
norepinephrine secretion, the renal tissue norepinephrine content
was decreased by the RF-RDN in the SHR (302 ± 41 vs. 159 ±
44 ng/g kidney, P b 0.001) and WKY (203 ± 33 vs. 145 ± 26 ng/g
kidney, p = 0.010). Conclusion: The RF-RDN demonstrated an anti-
hypertensive effect with a reduction of renal tissue norepinephrine
content in the SHR.
doi:10.1016/j.lfs.2013.12.087
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We report the case of a 49 year-old woman with pulmonary veno-
occlusive disease (PVOD) who was available to take a vasodilator,
sildenaﬁl, by dose adjustment. In 2001, she complained of dyspnea
on exertion and was diagnosed as idiopathic pulmonary arterial
hypertension; she started receiving beraprost sodium; however, she
discontinued it due to decrease of oxygen partial pressure. Based on
that history and on chest computed tomographic ﬁnding of smoothly
thickened interlobular septa, we diagnosed her with PVOD. In 2005,
bosentanwas administeredwithout any adverse reaction. In November
2012, she complained that dyspnea worsened; she showed the de-
crease of a six-minute walk distance (6 MWD) to 140 m and elevation
of right ventricular systolic pressure (RVSP) estimated by echocardiog-
raphy to 89 mmHg. Sildenaﬁl was initiated from a dose of 20 mg
per day and increased to 40 mg in addition to bosentan without acute
adverse events. Her dyspnea was markedly improved; 6 MWD was
extended to 225 m; and RVSP was diminished to 62 mmHg. When the
dose of sildenaﬁl reached 60 mg, she complained breath shortness
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